Welcome to the first italian blog about the stock market exchange in Second Life.
SL is a virtual world 3D created by Linden Lab, today there are more than 5 million subscribed members, with a strong economic growth around 10/15% per month. The stock market exchange is open since March 5 and today there are 40 companies.
In SL my name is Pasha Boucher and in RL I follow financial stock exchanges every day. On March 7 I have created a close private equity fund (asset 350000 L$) managed by Pb asset management. This company belongs to SL and I have founded it.
The blog is meant to inform and update the reader, and to analyze what is happening on the stock market in SL. I will also report on my own operativity on the WSE market.
This is going to be a mean to share my passion in Second Life and my passion in financial markets, to offer thoughtful insights on several aspects of the market, for example on rules and on fundamental analysis. It is aimed to become a reference for investors/traders/players.
Pasha Boucher
Translation by Mr Jo Bleac
SL is a virtual world 3D created by Linden Lab, today there are more than 5 million subscribed members, with a strong economic growth around 10/15% per month. The stock market exchange is open since March 5 and today there are 40 companies.
In SL my name is Pasha Boucher and in RL I follow financial stock exchanges every day. On March 7 I have created a close private equity fund (asset 350000 L$) managed by Pb asset management. This company belongs to SL and I have founded it.
The blog is meant to inform and update the reader, and to analyze what is happening on the stock market in SL. I will also report on my own operativity on the WSE market.
This is going to be a mean to share my passion in Second Life and my passion in financial markets, to offer thoughtful insights on several aspects of the market, for example on rules and on fundamental analysis. It is aimed to become a reference for investors/traders/players.
Pasha Boucher
Translation by Mr Jo Bleac
No comments:
Post a Comment